US Stock MarketDetailed Quotes

PSTX Poseida Therapeutics

Watchlist
  • 9.500
  • 0.0000.00%
Close Jan 7 16:00 ET
925.93MMarket Cap-15.08P/E (TTM)

About Poseida Therapeutics Company

Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors. Its products pipeline include autologous and allogeneic chimeric antigen receptor T cell, or CAR-T. The company was founded by Eric M. Ostertag in December 2014 and is headquartered in San Diego, CA.

Company Profile

SymbolPSTX
Company NamePoseida Therapeutics
Issue Price16.00
Founded2014
CEODr. Kristin Yarema, PhD
MarketNASDAQ
Employees330
Fiscal Year Ends12-31
Address9390 Towne Centre Drive,Suite 200
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-779-3100
Websitehttp://www.poseida.com

Company Executives

  • Name
  • Position
  • Salary
  • Syed Ali-aamir Rizvi, M.D.
  • Chief Medical Officer
  • --
  • Loren Wagner
  • Chief Operations Officer
  • --
  • Johanna M. Mylet, C.P.A.
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Harry J. Leonhardt, Esq.,J.D.
  • General Counsel, Chief Compliance Officer and Corporate Secretary
  • --
  • Alexander Chapman
  • Senior Vice President, Investor Relations and Corporate Communications
  • --
  • Sean A. Johnston
  • Director
  • --
  • Roger Brown
  • Director
  • --
Heat List
US
Overall
Symbol
Price
% Chg

No Data